Extended Data Table 2 Stage 1 (Moderna) adjusted pseudovirus neutralization day 29 and day 91 GMR ANCOVA modeling

From: Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial